ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
15 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
20K
|
7.0M
|
15
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
Newon
|
3.0K |
1.1M |
5 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
3.0K
|
1.1M
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
16 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
20K
|
7.0M
|
16
|
|
ASX - By Stock
|
PIL |
Re:
Thank you sellers
|
|
Newon
|
4 |
1.5K |
1 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
4
|
1.5K
|
1
|
|
ASX - By Stock
|
PIL |
Re:
Thank you sellers
|
|
Newon
|
4 |
1.5K |
9 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
4
|
1.5K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A Pre-IND meeting with FDA update
|
|
Newon
|
92 |
40K |
6 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
92
|
40K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A outperforms existing treatment for arthritis
|
|
Newon
|
179 |
59K |
1 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
179
|
59K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Sugar, Spice and Everything NYSE [ASX:IHL Update 2021]
|
|
Newon
|
37 |
16K |
2 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
37
|
16K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
7 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
20K
|
7.0M
|
7
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
Newon
|
206 |
79K |
2 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
206
|
79K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
11 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
20K
|
7.0M
|
11
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
7 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
20K
|
7.0M
|
7
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
5 |
12/12/20 |
12/12/20 |
ASX - By Stock
|
20K
|
7.0M
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
10 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
20K
|
7.0M
|
10
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
14 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
20K
|
7.0M
|
14
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
1 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
20K
|
7.0M
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Breakthru
|
|
Newon
|
38 |
11K |
1 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
38
|
11K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
5 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
20K
|
7.0M
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
10 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
20K
|
7.0M
|
10
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
1 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
20K
|
7.0M
|
1
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
8 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
20K
|
7.0M
|
8
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
1 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
20K
|
7.0M
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL Receives Ethics Approval for Phase 2 OSA Trial
|
|
Newon
|
46 |
10K |
5 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
46
|
10K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
Newon
|
603 |
145K |
0 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
603
|
145K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Options Exercise
|
|
Newon
|
84 |
19K |
11 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
84
|
19K
|
11
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Options Exercise
|
|
Newon
|
84 |
19K |
2 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
84
|
19K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
2 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
20K
|
7.0M
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Options exercise
|
|
Newon
|
29 |
7.4K |
5 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
29
|
7.4K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL commences IHL-675 (ARDS) animal study
|
|
Newon
|
112 |
30K |
2 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
112
|
30K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Exercise of Options
|
|
Newon
|
8 |
3.0K |
0 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
8
|
3.0K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Positive Results from IHL-675 (ARDS) animal study
|
|
Newon
|
189 |
48K |
2 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
189
|
48K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Alfred Hospital
|
|
Newon
|
25 |
5.8K |
6 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
25
|
5.8K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Record Sales for June Quarter
|
|
Newon
|
108 |
24K |
6 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
108
|
24K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
2 |
14/06/20 |
14/06/20 |
ASX - By Stock
|
20K
|
7.0M
|
2
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
2 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
20K
|
7.0M
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Options Exercise
|
|
Newon
|
41 |
10K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
41
|
10K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Newon
|
20K |
7.0M |
4 |
31/05/20 |
31/05/20 |
ASX - By Stock
|
20K
|
7.0M
|
4
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
Newon
|
603 |
145K |
1 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
603
|
145K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Newon
|
46 |
14K |
3 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
46
|
14K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-216A (TBI/concussion) accelerated FDA approval pathway
|
|
Newon
|
92 |
25K |
3 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
92
|
25K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A Hydroxychloroquine and CBD for ARDS
|
|
Newon
|
98 |
29K |
1 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
98
|
29K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
Newon
|
603 |
145K |
1 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
603
|
145K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
Newon
|
603 |
145K |
1 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
603
|
145K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-42x (OSA) accelerated FDA approval pathway
|
|
Newon
|
66 |
24K |
6 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
66
|
24K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Ann: RESUBMISSION - Quarterly Update and Appendix 4C
|
|
Newon
|
80 |
47K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
80
|
47K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Important dates
|
|
Newon
|
104 |
33K |
1 |
27/09/19 |
27/09/19 |
ASX - By Stock
|
104
|
33K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Important dates
|
|
Newon
|
104 |
33K |
3 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
104
|
33K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Ann: First Key Appointments to Medical Advisory Board
|
|
Newon
|
79 |
29K |
1 |
03/09/19 |
03/09/19 |
ASX - By Stock
|
79
|
29K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Oil Supply Agreement and Brand Launch
|
|
Newon
|
87 |
49K |
2 |
29/08/19 |
29/08/19 |
ASX - By Stock
|
87
|
49K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: First Key Appointments to Medical Advisory Board
|
|
Newon
|
79 |
29K |
1 |
29/08/19 |
29/08/19 |
ASX - By Stock
|
79
|
29K
|
1
|
|